-=Phibro Animal Health (PAHC) reported earnings on Mon 4 Nov 19 (a/h)

Phibro Animal Health misses by $0.05, misses on revs; reaffirms FY20 EPS guidance 

Reports Q1 (Sep) earnings of $0.19 per share, $0.05 worse than the S&P Capital IQ Consensus of $0.24; revenues fell 5.0% year/year to $190 mln vs the $199.22 mln S&P Capital IQ Consensus.

Gross profit decreased to 30.4% as compared to 32.9% for the three months ended September 30, 2018.

Co reaffirms guidance for FY20, sees EPS of $1.08-$1.14 vs. $1.12 S&P Capital IQ Consensus. Reaffirms expectation of current and new product sales growing 5-8% and acquisition and related sales growth of 4%.